The emerging approach of the medication represents a exciting advance in the management of type 2 diabetes. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide591403.widblog.com/96924857/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment